UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemiology of severe sepsis

Virulence, 2014-01, Vol.5 (1), p.4-11

2014

Volltextzugriff (PDF)

SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting

Annals of internal medicine, 2021-10, Vol.174 (10), p.1404-1408

2021

Volltextzugriff (PDF)

Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)

Critical care medicine, 2019-05, Vol.47 (5), p.632-642

2019

Volltextzugriff (PDF)

Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans

The New England journal of medicine, 2022-04, Vol.386 (14), p.1375-1377

2022

Volltextzugriff (PDF)

Mechanisms of Lin28-mediated miRNA and mRNA regulation--a structural and functional perspective

International Journal of Molecular Sciences, 2013-08, Vol.14 (8), p.16532-16553

2013

Volltextzugriff (PDF)

Three Decades of Sepsis in the United Kingdom: Tracing the Tides of Time

American journal of respiratory and critical care medicine, 2024-03, Vol.209 (5), p.468-469

2024

Volltextzugriff (PDF)

Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab

Intensive care medicine, 2019-10, Vol.45 (10), p.1360-1371

2019

Volltextzugriff (PDF)

COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods

Nature communications, 2022-06, Vol.13 (1), p.3647-6, Article 3647

2022

Volltextzugriff (PDF)

Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e849-e856

2022

Volltextzugriff (PDF)

A Chiral Thiourea as a Template for Enantioselective Intramolecular [2 + 2] Photocycloaddition Reactions

Journal of organic chemistry, 2016-08, Vol.81 (16), p.6965-6971

2016

Volltextzugriff (PDF)

Size matters! Peripheral blood leukocyte telomere length and survival after critical illness

The European respiratory journal, 2020-01, Vol.55 (1), p.1902114

2020

Volltextzugriff (PDF)

Relative Vaccine Effectiveness of a Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine Booster Dose Against the Omicron Variant

Clinical infectious diseases, 2022-12, Vol.75 (12), p.2161-2168

2022

Volltextzugriff (PDF)

Proportion and Cost of Unplanned 30-Day Readmissions After Sepsis Compared With Other Medical Conditions

JAMA : the journal of the American Medical Association, 2017-02, Vol.317 (5), p.530

2017

Volltextzugriff (PDF)

Identifying Survivors of Sepsis at Risk for Adverse Cardiovascular Outcomes

American journal of respiratory and critical care medicine, 2021-09, Vol.204 (5), p.500-501

2021

Volltextzugriff (PDF)

Reply to Wirth et al

Clinical infectious diseases, 2023-01, Vol.76 (1), p.177-178

2023

Volltextzugriff (PDF)

Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis

JAMA : the journal of the American Medical Association, 2010-06, Vol.303 (24), p.2495

2010

Volltextzugriff (PDF)

Very long-term survivors of in-hospital and out-of-hospital cardiac arrest show considerable impairment of daily life

Resuscitation, 2022-04, Vol.173, p.192-200

2022

Volltextzugriff (PDF)

Vaccine Effectiveness of 3 Versus 2 Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in a High-Risk National Population

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e579-e584

2022

Volltextzugriff (PDF)

Real-World Effectiveness of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in Preventing Confirmed Infection in Patients on Chronic Hemodialysis

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e617-e622

2022

Volltextzugriff (PDF)

Nirmatrelvir/Ritonavir Use and Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-Risk Population With COVID-19: A Matched Cohort Study

The Journal of infectious diseases, 2024-01, Vol.229 (1), p.147-154

2024

Volltextzugriff (PDF)

Molnupiravir Use and 30-Day Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-risk Population With COVID-19

The Journal of infectious diseases, 2023-10, Vol.228 (8), p.1033-1041

2023

Volltextzugriff (PDF)

Clinical epidemiology and outcomes of community acquired infection and sepsis among hospitalized patients in a resource limited setting in Northeast Thailand: A prospective observational study (Ubon-sepsis)

PloS one, 2018-09, Vol.13 (9), p.e0204509-e0204509

2018

Volltextzugriff (PDF)

Understanding the complex host response in sepsis: is diabetes the key?

Critical care (London, England), 2016-10, Vol.20 (1), p.321-321, Article 321

2016

Volltextzugriff (PDF)

Children with Chronic Disease Bear the Highest Burden of Pediatric Sepsis

The Journal of pediatrics, 2018-08, Vol.199, p.194-199.e1

2018

Volltextzugriff (PDF)

Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national population

EClinicalMedicine, 2021-10, Vol.40, p.101117-101117, Article 101117

2021

Volltextzugriff (PDF)

1 – 25 von 454

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(376)
Mit Volltextzugriff
(384)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(423)
Deutsch
(29)
Spanisch
(1)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Epidemiology of severe sepsis

SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting

Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)

Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans

Mechanisms of Lin28-mediated miRNA and mRNA regulation--a structural and functional perspective

Three Decades of Sepsis in the United Kingdom: Tracing the Tides of Time

Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab

COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods

Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population

A Chiral Thiourea as a Template for Enantioselective Intramolecular [2 + 2] Photocycloaddition Reactions

Size matters! Peripheral blood leukocyte telomere length and survival after critical illness

Relative Vaccine Effectiveness of a Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine Booster Dose Against the Omicron Variant

Proportion and Cost of Unplanned 30-Day Readmissions After Sepsis Compared With Other Medical Conditions

Identifying Survivors of Sepsis at Risk for Adverse Cardiovascular Outcomes

Reply to Wirth et al

Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis

Very long-term survivors of in-hospital and out-of-hospital cardiac arrest show considerable impairment of daily life

Vaccine Effectiveness of 3 Versus 2 Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in a High-Risk National Population

Real-World Effectiveness of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in Preventing Confirmed Infection in Patients on Chronic Hemodialysis

Nirmatrelvir/Ritonavir Use and Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-Risk Population With COVID-19: A Matched Cohort Study

Molnupiravir Use and 30-Day Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-risk Population With COVID-19

Clinical epidemiology and outcomes of community acquired infection and sepsis among hospitalized patients in a resource limited setting in Northeast Thailand: A prospective observational study (Ubon-sepsis)

Understanding the complex host response in sepsis: is diabetes the key?

Children with Chronic Disease Bear the Highest Burden of Pediatric Sepsis

Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national population

Suchergebnisse filtern